ArticleVaccines2022

The Chimeric Adenovirus (Ad5/35) Expressing Engineered Spike Protein Confers Immunity against SARS-CoV-2 in Mice and Non-Human Primates.

Seung-Phil Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.